Shares of Gerresheimer AG (ETR:GXI) have earned a consensus rating of “Hold” from the nine analysts that are presently covering the stock, Marketbeat Ratings reports. One equities research analyst has rated the stock with a sell recommendation, four have issued a hold recommendation and four have assigned a buy recommendation to the company. The average 1 year price target among brokerages that have updated their coverage on the stock in the last year is €79.80 ($93.88).

A number of equities analysts have weighed in on GXI shares. Independent Research GmbH set a €78.00 ($91.76) target price on Gerresheimer AG and gave the stock a “neutral” rating in a research report on Wednesday, July 19th. Berenberg Bank set a €85.00 ($100.00) price objective on Gerresheimer AG and gave the company a “buy” rating in a research note on Wednesday, May 24th. DZ Bank AG reiterated a “buy” rating on shares of Gerresheimer AG in a research note on Monday, July 17th. Deutsche Bank AG set a €82.00 ($96.47) price objective on Gerresheimer AG and gave the company a “buy” rating in a research note on Friday, July 7th. Finally, Kepler Capital Markets set a €70.00 ($82.35) price target on Gerresheimer AG and gave the stock a “sell” rating in a research note on Thursday, July 13th.

Gerresheimer AG (ETR GXI) opened at 69.02 on Tuesday. Gerresheimer AG has a 52-week low of €64.00 and a 52-week high of €79.47. The company’s 50-day moving average is €71.10 and its 200 day moving average is €73.16. The company has a market cap of €2.17 billion and a price-to-earnings ratio of 19.12.

COPYRIGHT VIOLATION WARNING: “Gerresheimer AG (GXI) Receives Consensus Recommendation of “Hold” from Analysts” was originally posted by American Banking News and is the property of of American Banking News. If you are viewing this report on another domain, it was stolen and republished in violation of US & international copyright and trademark laws. The correct version of this report can be accessed at https://www.americanbankingnews.com/2017/08/01/gerresheimer-ag-gxi-receives-consensus-recommendation-of-hold-from-analysts.html.

About Gerresheimer AG

Gerresheimer AG is a Germany-based company that is active in the pharmaceuticals and health care industry. It operates through two business segments: Plastics and Devices, and Primary Packaging Glass. The Plastics and Devices segment produces standard and customized products for drug delivery, such as insulin pens, inhalers, and prefillable syrings.

Analyst Recommendations for Gerresheimer AG (ETR:GXI)

Receive News & Ratings for Gerresheimer AG Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Gerresheimer AG and related companies with MarketBeat.com's FREE daily email newsletter.